Profile data is unavailable for this security.
About the company
LivaNova PLC is a medical device company focused on the development and delivery of important products and therapies for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The Company designs, develops, manufactures and sells products and therapies to provide improvements for both the head and heart. The Company operates in three reportable segments: Cardiopulmonary, Neuromodulation and Advanced Circulatory Support. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.
- Revenue in USD (TTM)1.02bn
- Net income in USD-86.25m
- Incorporated2015
- Employees2.90k
- LocationLivaNova PLC20 Eastbourne TerraceLONDON W2 6LGUnited KingdomGBR
- Phone+44 203 325 0662
- Websitehttps://www.livanova.com/en-us
Mergers & acquisitions
Acquired company | LIVN:NSQ since announced | Transaction value |
---|---|---|
ALung Technologies Inc | -44.56% | 110.00m |